PROTEIN DYNAMIC SOLUTIONS LAUNCHES NEW TECHNOLOGY FOR STREAMLINING DRUG DEVELOPMENT & MONITORING
Boston, MA – Protein Dynamic Solutions this week announced the commercial launch of ProteinMentor® , a state-of-the-art platform for critical quality attributes including deamidation, stability, and aggregation.
“Until now, Biopharma has lacked a comprehensive & efficient single protein characterization platform. ProteinMentor provides unique insight into protein structure for drug developability and monitoring and we are happy to launch during the 20th anniversary PEGS Boston Summit” said José E. Casellas, CEO of Protein Dynamic Solutions.
Dr Belinda Pastrana, CTO/CSO, Chairman of the Board and co-founder of Protein Dynamic Solutions introduced ProteinMentor at the PEGS Boston Summit in a talk entitled “Comprehensive Multi-Attribute Method for Biotherapeutic Developability Assessment and End-to-End Comparability”
ProteinMentor will be shipping from June 1st 2024.